|
Mechanism5-HT2 receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date24 Dec 1981 |
100 Clinical Results associated with Kamat Pharmatech LLC
0 Patents (Medical) associated with Kamat Pharmatech LLC
100 Deals associated with Kamat Pharmatech LLC
100 Translational Medicine associated with Kamat Pharmatech LLC